IL-6 hypothesis looking shaky as Kevzara fails COVID-19 trial Phil Taylor July 3, 2020
Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi and Regeneron’s Kevzara.
I heard Bill Gates talking about an inhaled MAB on his CNBC Interview, but only heard the names of Big Pharma when he was doing that interview. I dont think anyone will say our name until off OTC and validated for obvious reasons. Uplist & Data will be huge, and of course they will pile onto that headline from that idiot who was around for a whole 3 weeks that we all know is click bait.